PfizerUS7170811035PFEPFE
Financials
Market Cap
$157.31B5Y beta
0.60EPS (TTM)
$0.357Free Float
5.66BP/E ratio (TTM)
77.90Revenue (TTM)
$58.50BEBITDA (TTM)
$18.99BFree Cashflow (TTM)
-$4.45BPricing
Analyst Ratings
The price target is $32.22 and the stock is covered by 24 analysts.
Buy
10
Hold
14
Sell
0
Information
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. Its primary care products include Eliquis, Nurtec ODT/Vydura, Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Paxlovid and Lucira by Pfizer. Its specialty care products include Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo, Vyndaqel family, Genotropin, Sulperazon, Zavicefta, Medrol and Panzyga.